The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Myopericarditis (see under XIIc/d/g)
Publications
Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.
Cardiology research 2019 Feb;10;59-62 — 2019 Feb — 59-62
Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.
BMJ case reports 2019 Feb 01;12; — 2019 Feb 01
Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.
Journal of cardiovascular ultrasound 2012 Sep;20;154-6 — 2012 Sep — 154-6
Recurrent myopericarditis with extensive ulcerative colitis.
The Canadian journal of cardiology 2010 Dec;26;549-50 — 2010 Dec — 549-50
Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
International journal of colorectal disease 2006 Mar;21;199-200 — 2006 Mar — 199-200
The lung in inflammatory bowel disease.
Medicine 1993 May;72;151-83 — 1993 May — 151-83